The PPMD team is joined by leading Duchenne researchers to discuss exciting areas of research in development that hold promise for Duchenne, such as gene editing and non-viral delivery.
Panelists:
Kevin Flanigan, MD, Nationwide Children’s Hospital
Melissa Spencer, PhD, UCLA